Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,001 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Behçet's disease complicated by IgA nephropathy with nephrotic syndrome.
Hashimoto T, Toya Y, Kihara M, Yabana M, Inayama Y, Tanaka K, Iwatsubo K, Yanagi M, Oshikawa J, Kokuho T, Kuji T, Yoshida S, Tamura K, Umemura S. Hashimoto T, et al. Among authors: umemura s. Clin Exp Nephrol. 2008 Jun;12(3):224-7. doi: 10.1007/s10157-008-0029-6. Epub 2008 Jan 26. Clin Exp Nephrol. 2008. PMID: 18224274
Lipocalin-type prostaglandin d synthase in essential hypertension.
Hirawa N, Uehara Y, Yamakado M, Toya Y, Gomi T, Ikeda T, Eguchi Y, Takagi M, Oda H, Seiki K, Urade Y, Umemura S. Hirawa N, et al. Among authors: umemura s. Hypertension. 2002 Feb;39(2 Pt 2):449-54. doi: 10.1161/hy0202.102835. Hypertension. 2002. PMID: 11882588
Motor dysfunction in type 5 adenylyl cyclase-null mice.
Iwamoto T, Okumura S, Iwatsubo K, Kawabe J, Ohtsu K, Sakai I, Hashimoto Y, Izumitani A, Sango K, Ajiki K, Toya Y, Umemura S, Goshima Y, Arai N, Vatner SF, Ishikawa Y. Iwamoto T, et al. Among authors: umemura s. J Biol Chem. 2003 May 9;278(19):16936-40. doi: 10.1074/jbc.C300075200. Epub 2003 Mar 28. J Biol Chem. 2003. PMID: 12665504 Free article.
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T; Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators. Iino Y, et al. Among authors: umemura s. Clin Exp Nephrol. 2003 Sep;7(3):221-30. doi: 10.1007/s10157-003-0241-3. Clin Exp Nephrol. 2003. PMID: 14586719 Clinical Trial.
1,001 results